Agios Pharmaceuticals, Inc. (AGIO) on GreekSoup https://greeksoup.ai/stocks/us/agio/ Every dated entry in the public record on Agios Pharmaceuticals, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Agios Pharmaceuticals, Inc.: Form 144, SARAH GHEUENS plans to sell 7,866 shares worth $296,468 around 26 October 2026https://greeksoup.ai/stocks/us/agio/planned-sales/us:AGIO:planned-sale:2026-10-26:c7259edaf3Mon, 26 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: Gheuens Sarah (Chief Medical Officer) sold 500 shares (under a trading plan set in advance) at $37.52 on 22 October 2026, $18,760https://greeksoup.ai/stocks/us/agio/insiders/us:AGIO:insider:2026-10-23:8e305bacc4Fri, 23 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: Gheuens Sarah (Chief Medical Officer) sold 1,489 shares (under a trading plan set in advance) at $37.53 on 21 October 2026, $55,882https://greeksoup.ai/stocks/us/agio/insiders/us:AGIO:insider:2026-10-23:c090ed2419Fri, 23 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: Form 144, SARAH GHEUENS plans to sell 500 shares worth $18,760 around 22 October 2026https://greeksoup.ai/stocks/us/agio/planned-sales/us:AGIO:planned-sale:2026-10-22:5d560b6913Thu, 22 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: Form 144, SARAH GHEUENS plans to sell 1,489 shares worth $55,881 around 21 October 2026https://greeksoup.ai/stocks/us/agio/planned-sales/us:AGIO:planned-sale:2026-10-21:2f786bc711Wed, 21 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: short interest 6,894,856 shares at the 15 October 2026 settlement, 5.60 days to coverhttps://greeksoup.ai/stocks/us/agio/short-interest/us:AGIO:short-interest:2026-10-15:3eaaccc3e3Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: short interest 7,016,166 shares at the 30 September 2026 settlement, 6.44 days to coverhttps://greeksoup.ai/stocks/us/agio/short-interest/us:AGIO:short-interest:2026-09-30:9a3a1d649dWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: short interest 7,557,252 shares at the 15 September 2026 settlement, 9.46 days to coverhttps://greeksoup.ai/stocks/us/agio/short-interest/us:AGIO:short-interest:2026-09-15:140e71c500Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: Gilbert Cisneros (CA31) disclosed a purchase, $1,001 - $15,000, traded 20 August 2026https://greeksoup.ai/stocks/us/agio/congress/us:AGIO:congress:2026-09-10:b9afde68b1Thu, 10 Sep 2026 00:00:00 +0000House tradeHouse trade. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: short interest 7,535,054 shares at the 31 August 2026 settlement, 8.44 days to coverhttps://greeksoup.ai/stocks/us/agio/short-interest/us:AGIO:short-interest:2026-08-31:70129e1096Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: short interest 7,629,012 shares at the 14 August 2026 settlement, 6.99 days to coverhttps://greeksoup.ai/stocks/us/agio/short-interest/us:AGIO:short-interest:2026-08-14:f8249d2e58Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: Gheuens Sarah (Chief Medical Officer) sold 30,000 shares (under a trading plan set in advance) at $30.48 on 4 August 2026, $914,400https://greeksoup.ai/stocks/us/agio/insiders/us:AGIO:insider:2026-08-06:503b653854Thu, 06 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: Form 144, SARAH GHEUENS plans to sell 30,000 shares worth $914,283 around 4 August 2026https://greeksoup.ai/stocks/us/agio/planned-sales/us:AGIO:planned-sale:2026-08-04:5b125f7937Tue, 04 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: Schedule 13G/A filed by Farallon Capital Management, L.L.C., 9.9% of the classhttps://greeksoup.ai/stocks/us/agio/holders/us:AGIO:schedule-13:2026-08-03:35784879a5Mon, 03 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc.: short interest 6,840,722 shares at the 31 July 2026 settlement, 5.14 days to coverhttps://greeksoup.ai/stocks/us/agio/short-interest/us:AGIO:short-interest:2026-07-31:487d8d257fFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc. Q2 FY2026 results: revenue $45 million, net income -$101 millionhttps://greeksoup.ai/stocks/us/agio/results/fy2026-q2/us:AGIO:result:2026-07-30:b98f6daa97Thu, 30 Jul 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/agio/filings/us:AGIO:filing:2026-07-30:94040ff140Thu, 30 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Agios Pharmaceuticals, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/agio/filings/us:AGIO:filing:2026-07-30:58d3c014dcThu, 30 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>